Oculis Holding AG (OCS) Liabilities and Shareholders Equity (2021 - 2026)

Oculis Holding AG (OCS) posted quarterly Liabilities and Shareholders Equity of $311.6 million for Q1 2026, up 37.21% year-over-year from $227.1 million in Q1 2025, and up 5.54% quarter-over-quarter from $295.2 million in Q4 2025.

Oculis Holding AG (OCS) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends

Oculis Holding AG's Liabilities and Shareholders Equity history runs 6 years deep, the most recent figure standing at $311.6 million for Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity rose 37.21% year-over-year to $311.6 million; the TTM figure through Mar 2026 stood at $1.0 billion (up 56.29% YoY), while the FY2025 annual figure was $284.6 million, up 108.03% from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 stood at $311.6 million, up from $295.2 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $311.6 million in Q1 2026, with the low at $38.5 million in Q4 2022.
  • The 5-year median for Liabilities and Shareholders Equity is $150.0 million (2023), against an average of $175.0 million.
  • The sharpest annual moves came in 2022 and 2023: Liabilities and Shareholders Equity plunged 38.89% in 2022, then soared 235.12% in 2023.
  • Oculis Holding AG's Liabilities and Shareholders Equity stood at $38.5 million in 2022, then jumped by 235.12% to $128.9 million in 2023, then grew by 6.57% to $137.4 million in 2024, then jumped by 114.89% to $295.2 million in 2025, then advanced by 5.54% to $311.6 million in 2026.
  • Business Quant data shows OCS's Liabilities and Shareholders Equity at $311.6 million in Q1 2026, $295.2 million in Q4 2025, and $209.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 27.42 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 41.73 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 10.03 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 4.32 Bn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 9.18 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 15.59 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 19.82 Bn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 5.56 Bn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 2.10 Bn
10 Oculis Holding AG 879.09 Mn 590.21 Mn - 316.73 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 316.73 Mn
Mar 31, 2026 311.58 Mn
Dec 31, 2025 295.23 Mn
Sep 30, 2025 209.81 Mn
Jun 30, 2025 219.38 Mn
Mar 31, 2025 227.09 Mn
Dec 31, 2024 137.39 Mn
Sep 30, 2024 144.98 Mn
Jun 30, 2024 153.41 Mn
Mar 31, 2024 113.09 Mn
Dec 31, 2023 128.92 Mn
Sep 30, 2023 145.98 Mn
Jun 30, 2023 149.97 Mn
Dec 31, 2022 38.47 Mn
Dec 31, 2021 62.95 Mn